Intact parathyroid hormone and whole parathyroid hormone assay results disagree in hemodialysis patients under cinacalcet hydrochloride therapy

被引:11
作者
Koda, Ryo [1 ,2 ]
Kazama, Junichiro James [1 ,3 ]
Matsuo, Koji [1 ]
Kawamura, Kazuko [1 ]
Yamamoto, Suguru [1 ]
Wakasugi, Minako [1 ,4 ]
Takeda, Tetsuro [2 ]
Narita, Ichiei [1 ]
机构
[1] Niigata Univ, Grad Sch Med & Dent Sci, Dept Clin Nephrol & Rheumatol, Niigata, Niigata 9518510, Japan
[2] Dokkyo Univ, Dept Nephrol, Koshigaya Med Ctr, Koshigaya, Japan
[3] Niigata Univ, Med & Dent Hosp, Div Blood Purificat Therapy, Chuo Ku, Niigata, Niigata 9518510, Japan
[4] Niigata Univ, Grad Sch Med & Dent Hosp, Ctr Interorgan Res, Niigata, Niigata 9518510, Japan
关键词
Intact PTH; Whole PTH; Cinacalcet hydrochloride; Hemodialysis; SECONDARY HYPERPARATHYROIDISM; DIALYSIS PATIENTS; PTH; SECRETION;
D O I
10.1007/s10157-014-1045-3
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
The parathyroid gland secretes 1-84 and 7-84 parathyroid hormone (PTH) fragments, and its regulation is dependent on stimulation of the extracellular calcium-sensing receptor. While the intact PTH system detects both PTH fragments, the whole PTH system detects the 1-84PTH but not the 7-84PTH. Cinacalcet hydrochloride (CH) binds to calcium-sensing receptor as a calcimimetic. Here we investigated the role of CH treatment in the assessment of parathyroid gland function. Stable adult dialysis patients for whom CH therapy was planned were included. Patients for whom CH therapy was not planned were simultaneously included as the control group. The CH group (n = 44) showed significantly higher circulating levels of Ca, intact PTH, and whole PTH, before the CH treatment than the control group (n = 112). The Ca, intact PTH, and whole PTH levels decreased along with the CH therapy, and the Ca levels became comparable in the 8th week of treatment and thereafter. The CH group in the 8th week and thereafter showed significantly lower whole/intact PTH ratios than the control group, while the whole/intact PTH ratio was not significantly different between before and during the CH therapy. A multiple regression analysis revealed that the whole/intact PTH ratio was almost constant, but both the serum Ca level and a CH therapy could potentially modify the fixed number. When the whole PTH levels were estimated by intact PTH levels using the relationship between them in the control group, the levels were clearly overestimated in the CH group. Although the direct effect of CH on the whole/intact PTH ratio is masked by its hypocalcemic action, we could successfully demonstrate that the ratio in CH users is lower than that in the non-users with comparable levels of serum Ca. Evaluating parathyroid function with intact PTH according to the clinical practice guidelines in patients being treated with CH may lead to significant overestimation and subsequent overtreatment.
引用
收藏
页码:710 / 717
页数:8
相关论文
共 20 条
[11]   Direct comparison between two 1-84PTH assays in dialysis patients [J].
Kazama, JJ ;
Yamamoto, S ;
Kameda, S ;
Maruyama, H ;
Narita, I ;
Shigematsu, T ;
Gejyo, F .
NEPHRON CLINICAL PRACTICE, 2005, 99 (01) :C8-C12
[12]   Intact PTH assay overestimates true 1-84 PTH levels after maxacalcitol therapy in dialysis patients with secondary hyperparathyroidism [J].
Kazama, JJ ;
Omori, K ;
Higuchi, N ;
Takahashi, N ;
Ito, Y ;
Maruyama, H ;
Narita, I ;
Cantor, TL ;
Gao, P ;
Gejyo, F .
NEPHROLOGY DIALYSIS TRANSPLANTATION, 2004, 19 (04) :892-897
[13]   Circulating 1-84 PTH and large C-terminal PTH fragment levels in uremia [J].
Junichiro James Kazama ;
Tsukasa Omori ;
Isei Ei ;
Kyoko Ei ;
Mizue Oda ;
Hiroki Maruyama ;
Ichiei Narita ;
Fumitake Gejyo ;
Takashi Shigematsu ;
Masafumi Fukagawa .
Journal of Clinical and Experimental Nephrology, 2003, 7 (2) :144-149
[14]   The Regulation of Parathyroid Hormone Secretion and Synthesis [J].
Kumar, Rajiv ;
Thompson, James R. .
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2011, 22 (02) :216-224
[15]   First- and second-generation immunometric PTH assays during treatment of hyperparathyroidism with cinacalcet HCl [J].
Martin, KJ ;
Jüppner, H ;
Sherrard, DJ ;
Goodman, WG ;
Kaplan, MR ;
Nassar, G ;
Campbell, P ;
Curzi, M ;
Charytan, C ;
McCary, LC ;
Guo, MD ;
Turner, SA ;
Bushinsky, DA .
KIDNEY INTERNATIONAL, 2005, 68 (03) :1236-1243
[16]   Improved assessment of bone turnover by the PTH-(1-84) large C-PTH fragments ratio in ESRD patients [J].
Monier-Faugere, MC ;
Geng, ZP ;
Mawad, H ;
Friedler, RM ;
Gao, P ;
Cantor, TL ;
Malluche, HH .
KIDNEY INTERNATIONAL, 2001, 60 (04) :1460-1468
[17]   Parathyroid hormone secretion and action: Evidence for discrete receptors for the carboxyl-terminal region and related biological actions of carboxyl-terminal ligands [J].
Murray, TM ;
Rao, LG ;
Divieti, P ;
Bringhurst, FR .
ENDOCRINE REVIEWS, 2005, 26 (01) :78-113
[18]   Functional proteins involved in regulation of intracellular Ca2+ for drug development:: The extracellular calcium receptor and an innovative medical approach to control secondary hyperparathyroidism by calcimimetics [J].
Nagano, N ;
Nemeth, EF .
JOURNAL OF PHARMACOLOGICAL SCIENCES, 2005, 97 (03) :355-360
[19]   Inter-method variability in PTH measurement: Implication for the care of CKD patients [J].
Souberbielle, J-C ;
Boutten, A. ;
Carlier, M-C ;
Chevenne, D. ;
Coumaros, G. ;
Lawson-Body, E. ;
Massart, C. ;
Monge, M. ;
Myara, J. ;
Parent, X. ;
Plouvier, E. ;
Houillier, P. .
KIDNEY INTERNATIONAL, 2006, 70 (02) :345-350
[20]   Cinacalcet Reduces the Set Point of the PTH-Calcium Curve [J].
Valle, Casimiro ;
Rodriguez, Mariano ;
Santamaria, Rafael ;
Almaden, Yolanda ;
Rodriguez, Maria E. ;
Canadillas, Sagrario ;
Martin-Malo, Alejandro ;
Aljama, Pedro .
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2008, 19 (12) :2430-2436